Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

PROF - Profound Medical Corp


IEX Last Trade
9.15
-0.190   -2.077%

Share volume: 29,555
Last Updated: Fri 30 Aug 2024 09:55:12 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$9.34
-0.19
-2.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
15%
Profitability 0%
Dept financing 22%
Liquidity 62%
Performance 16%
Company vs Stock growth
vs
Performance
5 Days
1.33%
1 Month
-13.27%
3 Months
22.00%
6 Months
3.04%
1 Year
-0.11%
2 Year
32.03%
Key data
Stock price
$9.15
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$7.11 - $11.69
52 WEEK CHANGE
$0.01
MARKET CAP 
224.009 M
YIELD 
N/A
SHARES OUTSTANDING 
24.482 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/31/2024
BETA 
1.05
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$26,388
AVERAGE 30 VOLUME 
$35,285
Company detail
CEO:
Region: US
Website: profoundmedical.com
Employees: 140
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

an inside out approach to prostate ablation profound medical is a canadian medical device company that has developed a unique and minimally invasive procedure to ablate the prostate gland in prostate cancer patients. profound’s novel technology combines real-time mr imaging with transurethral therapeutic ultrasound and closed-loop thermal feedback control. it provides a highly precise treatment tailored to patient-specific anatomy and pathology. this method of prostate ablation offers short treatment times and low morbidity, allowing for fast patient recovery. the potential of this technology is currently being demonstrated in clinical trials. for more information, visit profoundmedical.com

Recent news